Abstract
Background
The cell adhesion molecule close homologue of L1 (CHL1) is a potential tumour suppressor and was recently detected in non-small cell lung cancer (NSCLC) specimens. The expression pattern, prognostic, and functional role of CHL1 in NSCLCs is unknown.
Methods
We evaluated the protein expression of CHL1 by immunohistochemistry in 2161 NSCLC patients based on a tissue microarray. The results were correlated with clinical, histopathological, and patient survival data (Chi square test, t test, and log-rank test, respectively). A multivariate analysis (Cox regression) was performed to validate its impact on patients’ survival.
Results
CHL1 was expressed in NSCLC patients and was significantly overexpressed in lung adenocarcinomas and squamous cell carcinomas compared to neuroendocrine and large cell carcinomas of the lung (p < 0.001). CHL1 expression was associated with the T stage in adenocarcinomas (p = 0.011) and with metastatic lymph node status and UICC stage in squamous cell carcinomas (p = 0.034 and p = 0.035, respectively). Increased CHL1 expression was associated with improved survival in univariate (p = 0.031) and multivariate analyses (odds ratio 0.797, 95% confidence interval 0.677–0.939, p = 0.007).
Conclusion
The prognostic significance of CHL1 makes it a potential prognostic and therapeutic target and underlines its role as a tumour suppressor. Further validation studies and functional analyses are needed to investigate its potential role in tumourigenesis and dissemination.
Similar content being viewed by others
References
Browse the SEER Cancer Statistics Review 1975–2015 [Internet]. SEER. [cited 2019 Apr 5]. https://seer.cancer.gov/csr/1975_2015/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.01
Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze’ev A (2002) Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev. 16(16):2058–2072
Dancau A-M, Simon R, Mirlacher M, Sauter G (2016) Tissue microarrays. Methods Mol Biol Clifton NJ. 1381:53–65
Frints SGM, Marynen P, Hartmann D, Fryns J-P, Steyaert J, Schachner M et al (2003) CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum Mol Genet 12(13):1463–1474
Górka B, Skubis-Zegadło J, Mikula M, Bardadin K, Paliczka E, Czarnocka B (2007) NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. Br J Cancer 97(4):531–538
He L-H, Ma Q, Shi Y-H, Ge J, Zhao H-M, Li S-F et al (2013) CHL1 is involved in human breast tumorigenesis and progression. Biochem Biophys Res Commun 438(2):433–438
Klat J, Mladenka A, Dvorackova J, Bajsova S, Simetka O (2019) L1CAM as a negative prognostic factor in endometrioid endometrial adenocarcinoma FIGO stage IA-IB. Anticancer Res 39(1):421–424
Kotani N, Ida Y, Nakano T, Sato I, Kuwahara R, Yamaguchi A et al (2018) Tumor-dependent secretion of close homolog of L1 results in elevation of its circulating level in mouse model for human lung tumor. Biochem Biophys Res Commun. 501(4):982–987
Lo Russo G, Imbimbo M, Corrao G, Proto C, Signorelli D, Vitali M et al (2017) Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases. Oncotarget. 8(35):59889–59900
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A et al (2017) CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer. Oncotarget. 8(9):15789–15801
Naus S, Richter M, Wildeboer D, Moss M, Schachner M, Bartsch JW (2004) Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J Biol Chem 279(16):16083–16090
Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC et al (2018) CHL1 gene acts as a tumor suppressor in human neuroblastoma. Oncotarget. 9(40):25903–25921
Raveh S, Gavert N, Ben-Ze’ev A (2009) L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 282(2):137–145
Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S et al (2014) Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 25(Suppl 3):iii27–iii39
Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24(3):227–235
Sakurai K, Migita O, Toru M, Arinami T (2002) An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia. Mol Psychiatry. 7(4):412–415
Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA et al (2011) Differential expression of CHL1 gene during development of major human cancers. PLoS One 6(3):e15612
Shen M, Ren X (2017) Highlights on immune checkpoint inhibitors in non-small cell lung cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 39(3):1010428317695013
Siesser PF, Maness PF (2009) L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell Adhes Migr. 3(3):275–277
Simon R, Mirlacher M, Sauter G (2010) Immunohistochemical analysis of tissue microarrays. Methods Mol Biol Clifton NJ. 664:113–126
Tachezy M, Zander H, Marx AH, Gebauer F, Rawnaq T, Kaifi JT et al (2011) ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. J Surg Res 170(2):226–232
Tang H, Jiang L, Zhu C, Liu R, Wu Y, Yan Q et al (2019) Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Oncogene 8:1
Tian W, Li X, Ren Y, Yin Z, Quan X, Zheng C et al (2018) CHL1 gene polymorphisms increase lung cancer susceptibility. Oncotarget. 9(17):13545–13550
Wei MH, Karavanova I, Ivanov SV, Popescu NC, Keck CL, Pack S et al (1998) In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules. Hum Genet 103(3):355–364
Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U et al (2006) Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94(1):128–135
Yu W, Zhu K, Wang Y, Yu H, Guo J. Overexpression of miR-21-5p promotes proliferation and invasion of colon adenocarcinoma cells through targeting CHL1. Mol Med [Internet]. 2018 Jul 16 [cited 2019 Mar 18];24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048725/
Zamay TN, Zamay GS, Kolovskaya OS, Zukov RA, Petrova MM, Gargaun A et al (2017) Current and prospective protein biomarkers of lung cancer. Cancers. 9(11):155
Zecchini S, Cavallaro U (2010) Neural cell adhesion molecule in cancer: expression and mechanisms. Adv Exp Med Biol 663:319–333
Acknowledgements
We thank the patients who willingly and generously provided data and samples for research purposes.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Jenny Hötzel declares that she has no conflict of interest. Nathaniel Melling declares that he has no conflict of interest. Julia Müller declares that she has no conflict of interest. Adam Polonski declares that he has no conflict of interest. Gerrit Wolters-Eisfeld declares that he has no conflict of interest. Jakob R. Izbicki declares that he has no conflict of interest. Karl-F. Karstens declares that he has no conflict of interest. Michael Tachezy declares that he has no conflict of interest.
Ethical approval
Retrieval of tissue and clinical data was performed according to the regulations of the local medical association’s ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards as well as data safety laws.
Informed consent
Informed consent was obtained from all patients enrolled in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hötzel, J., Melling, N., Müller, J. et al. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol 145, 2285–2292 (2019). https://doi.org/10.1007/s00432-019-02989-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-02989-x